Entry |
|
Name |
Lidocaine hydrochloride monohydrate; Lidocaine (TN); Zingo (TN) |
Product |
|
Generic |
1% LIDOCAINE HCI (HF Acquisition Co LLC), 1% LIDOCAINE HCI (HF Acquisition Co LLC), 2% LIDOCAINE HCI (HF Acquisition Co LLC), 2% LIDOCAINE HCI (HF Acquisition Co. LLC), LIDOCAINE HCI (HF Acquisition Co LLC), LIDOCAINE HCI (HF Acquisition Co. LLC), LIDOCAINE HCL (HF Acquisition Co LLC), LIDOCAINE HCL (HF Acquisition Co LLC), LIDOCAINE HYDROCHLORIDE (A-S Medication Solutions), LIDOCAINE HYDROCHLORIDE (A-S Medication Solutions), LIDOCAINE HYDROCHLORIDE (Asclemed USA), LIDOCAINE HYDROCHLORIDE (Cardinal Health 107), LIDOCAINE HYDROCHLORIDE (Golden State Medical Supply), LIDOCAINE HYDROCHLORIDE (HF Acquisition Co LLC), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Henry Schein), LIDOCAINE HYDROCHLORIDE (Hospira), LIDOCAINE HYDROCHLORIDE (Hospira), LIDOCAINE HYDROCHLORIDE (Hospira), LIDOCAINE HYDROCHLORIDE (Medical Purchasing Solutions), LIDOCAINE HYDROCHLORIDE (Medical Purchasing Solutions), LIDOCAINE HYDROCHLORIDE (Medical Purchasing Solutions), LIDOCAINE HYDROCHLORIDE (Medical Purchasing Solutions), LIDOCAINE HYDROCHLORIDE (Medical Purchasing Solutions), LIDOCAINE HYDROCHLORIDE (Medical Purchasing Solutions), LIDOCAINE HYDROCHLORIDE (Preferred Pharmaceuticals), LIDOCAINE HYDROCHLORIDE (REMEDYREPACK), NA (SINTETICA SA), NA (Sintetica US LLC) |
Formula |
C14H22N2O. HCl. H2O
|
Exact mass |
288.1605
|
Mol weight |
288.81
|
Structure |

|
Simcomp |
|
Class |
Cardiovascular agent
DG01653 Antiarrhythmics
DG01652 Class I antiarrhythmic agent
DG01651 Class Ib antiarrhythmic agent
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
Remark |
Therapeutic category: | 1214 |
Product (DG00196): | D00358<JP/US> D02086<JP/US> D08127<JP/US> |
Product (mixture): | D04813<JP/US> |
|
Efficacy |
Anesthetic (topical), Antiarrhythmic, Sodium channel blocker |
Target |
|
Pathway |
hsa04261 | Adrenergic signaling in cardiomyocytes |
|
Metabolism |
Enzyme: CYP1A2 [HSA: 1544], CYP3A4 [HSA: 1576]
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01B ANTIARRHYTHMICS, CLASS I AND III
C01BB Antiarrhythmics, class Ib
C01BB01 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AD Local anesthetics
C05AD01 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
D DERMATOLOGICALS
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04AB Anesthetics for topical use
D04AB01 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BB Amides
N01BB02 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
R RESPIRATORY SYSTEM
R02 THROAT PREPARATIONS
R02A THROAT PREPARATIONS
R02AD Anesthetics, local
R02AD02 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01H LOCAL ANESTHETICS
S01HA Local anesthetics
S01HA07 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
S02 OTOLOGICALS
S02D OTHER OTOLOGICALS
S02DA Analgesics and anesthetics
S02DA01 Lidocaine
D08127 Lidocaine hydrochloride monohydrate <JP/US>
USP drug classification [BR:br08302]
Anesthetics
Local Anesthetics
Lidocaine
D08127 Lidocaine hydrochloride monohydrate
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
121 Local anesthetics
1214 Xylidines
D08127 Lidocaine hydrochloride monohydrate
Drug groups [BR:br08330]
Cardiovascular agent
DG01653 Antiarrhythmics
DG01652 Class I antiarrhythmic agent
DG01651 Class Ib antiarrhythmic agent
DG00196 Lidocaine
D08127 Lidocaine hydrochloride monohydrate
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
DG00196 Lidocaine
D08127 Lidocaine hydrochloride monohydrate
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00196 Lidocaine
D08127 Lidocaine hydrochloride monohydrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00196 Lidocaine
D08127 Lidocaine hydrochloride monohydrate
Drug classes [BR:br08332]
Cardiovascular agent
DG01653 Antiarrhythmics
D08127 Lidocaine hydrochloride monohydrate
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Sodium channels
SCN1A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN2A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN3A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN4A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN5A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN8A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN9A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN10A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
SCN11A
D08127 Lidocaine hydrochloride monohydrate <JP/US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08127
Drug groups [BR:br08330]
Cardiovascular agent
DG01653 Antiarrhythmics
DG01652 Class I antiarrhythmic agent
DG01651 Class Ib antiarrhythmic agent
DG00196 Lidocaine
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
DG00196 Lidocaine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00196 Lidocaine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00196 Lidocaine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 19
1 C8y C 19.5300 -17.9200
2 N1b N 20.7200 -18.6200
3 C8y C 18.2700 -18.6200
4 C8y C 19.5300 -16.5200
5 C5a C 21.9800 -17.9200
6 C8x C 17.0800 -17.9200
7 C1a C 18.2700 -20.0200
8 C8x C 18.2700 -15.8200
9 C1a C 20.7200 -15.8200
10 C1b C 23.1700 -18.6200
11 O5a O 21.9800 -16.8700
12 C8x C 17.0800 -16.5200
13 N1c N 24.4300 -17.9200
14 C1b C 25.6900 -18.6200
15 C1b C 24.4300 -16.5200
16 C1a C 26.8800 -17.9200
17 C1a C 25.6900 -15.8200
18 X Cl 31.2200 -17.3600
19 O0 O 31.2900 -14.9100
BOND 17
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 1
7 4 8 2
8 4 9 1
9 5 10 1
10 5 11 2
11 6 12 2
12 10 13 1
13 13 14 1
14 13 15 1
15 14 16 1
16 15 17 1
17 8 12 1
|
|